Nashville, Tenn., May 2009 – The attorneys at Harwell Howard Hyne Gabbert & Manner advised OralDNA Labs Inc. and its management team, led by CEO Brian Carr and Chairman Tom Nabors, in the company’s sale to Quest Diagnostics Incorporated [NYSE: DGX], based in Madison, New Jersey. 

OralDNA is a specialty diagnostics company established to bring medical laboratory diagnostics to the dental field.   For more information, please visit www.oraldna.com.

H3GM previously represented Mr. Carr in other ventures, most recently American Esoteric Laboratories, including its formation, venture capital funding, growth through strategic acquisitions, and eventual sale to Sonic Healthcare, a public Australian healthcare company, for over $180 million.